New trends in brain tumor immunity with the opportunities of lymph nodes targeted drug delivery

[1]  G. Shim,et al.  Nanoparticles for Lymph Node-Directed Delivery , 2023, Pharmaceutics.

[2]  D. Brat,et al.  Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment , 2023, The Journal of clinical investigation.

[3]  Steven R. Abram,et al.  Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma , 2022, JAMA oncology.

[4]  Qiaobing Xu,et al.  Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Altmann,et al.  Meningeal lymphatic vessels mediate neurotropic viral drainage from the central nervous system , 2022, Nature Neuroscience.

[6]  M. Prinz,et al.  SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis , 2022, Journal of Hepatology.

[7]  Wen-da Wang,et al.  Evoking pyroptosis with nanomaterials for cancer immunotherapy: Current boom and novel outlook , 2022, Nano TransMed.

[8]  M. Rasmussen,et al.  Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line , 2022, Current issues in molecular biology.

[9]  Leila A. Mashouf,et al.  CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future , 2022, Frontiers in Immunology.

[10]  James E. Dahlman,et al.  Non-liver mRNA Delivery. , 2021, Accounts of chemical research.

[11]  R. Soffietti,et al.  Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance , 2021, International journal of molecular sciences.

[12]  Quanyin Hu,et al.  Vaccine delivery systems toward lymph nodes , 2021, Advanced drug delivery reviews.

[13]  Xing-jie Liang,et al.  Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies , 2021, Acta pharmaceutica Sinica. B.

[14]  Alexandra Flemming.  mRNA vaccine shows promise in autoimmunity , 2021, Nature reviews. Immunology.

[15]  S. Trépout,et al.  Light-Gated Nano-Porous Capsules from Stereoisomer-Directed Self-Assemblies. , 2020, ACS nano.

[16]  Minjie Sun,et al.  Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot , 2020, Proceedings of the National Academy of Sciences.

[17]  Jinming Gao,et al.  Polycarbonate-based ultra-pH sensitive nanoparticles improve therapeutic window , 2020, Nature Communications.

[18]  S. Sambhara,et al.  Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines , 2020, Vaccines.

[19]  Matthew S. Miller,et al.  Immunological considerations for COVID-19 vaccine strategies , 2020, Nature Reviews Immunology.

[20]  D. Curiel,et al.  Adenoviral vectors for in vivo delivery of CRISPR-Cas gene editors. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[21]  A. Harari,et al.  Antitumour dendritic cell vaccination in a priming and boosting approach , 2020, Nature Reviews Drug Discovery.

[22]  Hiroyuki Koide,et al.  Recent advances in siRNA delivery mediated by lipid-based nanoparticles , 2020, Advanced Drug Delivery Reviews.

[23]  Y. Hu,et al.  Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial , 2020, The Lancet.

[24]  Zhicheng Le,et al.  Therapeutic Delivery to the Brain via the Lymphatic Vasculature. , 2020, Nano letters.

[25]  Takashi Nakamura,et al.  Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy. , 2020, Advanced drug delivery reviews.

[26]  H. Friedman,et al.  Management of glioblastoma: State of the art and future directions. , 2020, CA: a cancer journal for clinicians.

[27]  D. Oupický,et al.  Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy , 2020, Science Advances.

[28]  S. Thomas,et al.  Programmable multistage drug delivery to lymph nodes , 2020, Nature Nanotechnology.

[29]  Q. Luo,et al.  Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response , 2020, Nature Communications.

[30]  F. Tang,et al.  Meningeal lymphatic vessels regulate brain tumor drainage and immunity , 2020, Cell Research.

[31]  Nathan J. Castro,et al.  The current versatility of polyurethane 3D-printing for biomedical applications. , 2020, Tissue engineering. Part B, Reviews.

[32]  C. Foged,et al.  Opportunities and Challenges in the Delivery of mRNA-Based Vaccines , 2020, Pharmaceutics.

[33]  A. Iwasaki,et al.  VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours , 2020, Nature.

[34]  J. Sampson,et al.  Brain immunology and immunotherapy in brain tumours , 2019, Nature Reviews Cancer.

[35]  Michele De Palma,et al.  Engineering dendritic cell vaccines to improve cancer immunotherapy , 2019, Nature Communications.

[36]  A. Ribas,et al.  Tumour-intrinsic resistance to immune checkpoint blockade , 2019, Nature Reviews Immunology.

[37]  Christopher M. Jackson,et al.  Mechanisms of immunotherapy resistance: lessons from glioblastoma , 2019, Nature Immunology.

[38]  G. Koh,et al.  Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid , 2019, Nature.

[39]  S. Thomas,et al.  Material design for lymph node drug delivery , 2019, Nature Reviews Materials.

[40]  J. Heys,et al.  Analysis of convective and diffusive transport in the brain interstitium , 2019, Fluids and Barriers of the CNS.

[41]  Hua Sun,et al.  Composition design and medical application of liposomes. , 2019, European journal of medicinal chemistry.

[42]  Zhuang Liu,et al.  Nanoparticle‐Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy , 2019, Advanced materials.

[43]  C. June,et al.  Immunotherapy for Glioblastoma: Adoptive T-cell Strategies , 2018, Clinical Cancer Research.

[44]  G. Linette,et al.  CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges , 2018, Neuro-oncology.

[45]  Jonathan Kipnis,et al.  The Meningeal Lymphatic System: A New Player in Neurophysiology , 2018, Neuron.

[46]  Kevin M. Johnson,et al.  Meningeal Lymphatic Vessel Flow Runs Countercurrent to Venous Flow in the Superior Sagittal Sinus of the Human Brain , 2018, Tomography.

[47]  Christopher C. Overall,et al.  CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature , 2018, Nature Neuroscience.

[48]  Christopher C. Overall,et al.  Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease , 2018, Nature.

[49]  Scott T. Acton,et al.  Functional aspects of meningeal lymphatics in aging and Alzheimer’s disease , 2018, Nature.

[50]  Steven R. Abram,et al.  First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma , 2018, Journal of Translational Medicine.

[51]  N. Oku,et al.  Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer. , 2018, Molecular pharmaceutics.

[52]  K. Shull,et al.  Sustained micellar delivery via inducible transitions in nanostructure morphology , 2018, Nature Communications.

[53]  R. Thorne,et al.  Molecular characterization of perivascular drainage pathways in the murine brain , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[54]  K. Alitalo,et al.  Development and plasticity of meningeal lymphatic vessels , 2017, The Journal of experimental medicine.

[55]  M. Detmar,et al.  Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice , 2017, Nature Communications.

[56]  M. Meyerand,et al.  Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery , 2017, The Journal of physiology.

[57]  Zhijian J. Chen,et al.  A STING-Activating Nanovaccine for Cancer Immunotherapy , 2017, Nature nanotechnology.

[58]  D. Quail,et al.  The Microenvironmental Landscape of Brain Tumors. , 2017, Cancer cell.

[59]  D. Lodygin,et al.  Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid , 2016, Nature.

[60]  H. Goossens,et al.  Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy , 2015, Pharmacological Reviews.

[61]  M. Lim,et al.  Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites , 2015, Front. Oncol..

[62]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[63]  Britta Engelhardt,et al.  Brain barriers: Crosstalk between complex tight junctions and adherens junctions , 2015, The Journal of cell biology.

[64]  Harald Sontheimer,et al.  Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells , 2014, Nature Communications.

[65]  Z. Berneman,et al.  Clinical use of dendritic cells for cancer therapy. , 2014, The Lancet. Oncology.

[66]  Daniel Anderson,et al.  Delivery materials for siRNA therapeutics. , 2013, Nature materials.

[67]  Sarah Seifert,et al.  Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape , 2013, Nature Biotechnology.

[68]  Tian Feng,et al.  Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. , 2013, The Journal of clinical investigation.

[69]  Xiaoyuan Chen,et al.  Differentiation of Reactive and Tumor Metastatic Lymph Nodes with Diffusion-weighted and SPIO-Enhanced MRI , 2013, Molecular Imaging and Biology.

[70]  G. E. Vates,et al.  A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.

[71]  F. Lai,et al.  New methods for lipid nanoparticles preparation. , 2011, Recent patents on drug delivery & formulation.

[72]  K. G. Rajeev,et al.  Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.

[73]  G. Sainte-Marie,et al.  The Lymph Node Revisited: Development, Morphology, Functioning, and Role in Triggering Primary Immune Responses , 2010, Anatomical record.

[74]  Kinam Park,et al.  Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction , 2010, Expert opinion on drug delivery.

[75]  I. Bechmann,et al.  Perivascular Spaces and the Two Steps to Neuroinflammation , 2008, Journal of neuropathology and experimental neurology.

[76]  S. Yuan,et al.  Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism. , 2007, American journal of physiology. Heart and circulatory physiology.

[77]  I. Bechmann,et al.  T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa , 2006, Journal of leukocyte biology.

[78]  Sai T Reddy,et al.  In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[79]  P. Brown.  Lymphatic system: Unlocking the drains , 2005, Nature.

[80]  N. Joan Abbott,et al.  Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology , 2004, Neurochemistry International.

[81]  Ulrich H. von Andrian,et al.  Homing and cellular traffic in lymph nodes , 2003, Nature Reviews Immunology.

[82]  S. Jalkanen,et al.  Mannose Receptor Is a Novel Ligand for L-Selectin and Mediates Lymphocyte Binding to Lymphatic Endothelium , 2001, The Journal of experimental medicine.

[83]  M. Bradbury,et al.  Factors influencing exit of substances from cerebrospinal fluid into deep cervical lymph of the rabbit. , 1983, The Journal of physiology.

[84]  P. Medawar.  Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. , 1948, British journal of experimental pathology.

[85]  Michael Detmar,et al.  A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules , 2015 .

[86]  R. Daneman,et al.  The blood-brain barrier. , 2015, Cold Spring Harbor perspectives in biology.

[87]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[88]  R. Carare,et al.  Lymphatic drainage of the brain and the pathophysiology of neurological disease , 2008, Acta Neuropathologica.

[89]  W. Leitner,et al.  Genetic immunization with LYVE-1 cDNA yields function-blocking antibodies against native protein. , 2006, Microvascular research.

[90]  S. Strand,et al.  Scintigraphic method to quantify the passage from brain parenchyma to the deep cervical lymph nodes in rats , 2004, European Journal of Nuclear Medicine.

[91]  Edgar G. Engleman,et al.  Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells , 1996, Nature Medicine.

[92]  M. Kozma,et al.  New contributions to the anatomical connections of the brain and the lymphatic system. , 1966, Acta anatomica.